| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/14/2001 | EP1082324A1 Imidazopyridine thrombin inhibitors |
| 03/14/2001 | EP1082321A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082320A1 Novel substituted imidazole compounds |
| 03/14/2001 | EP1082303A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP0831817B1 Antigen-processing cell-targeted conjugates comprising a polyamino acid backbone and a non-steroidal anti-inflammatory agent |
| 03/14/2001 | EP0812205B1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0701455B1 Plasma-like solution |
| 03/14/2001 | CN1287008A Achyranthis bidentatae glycopeptide and its preparation |
| 03/14/2001 | CN1063180C 5H, 10H-imidazo [1,2-a] indeno [1,2-e] pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6201006 Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 03/13/2001 | US6200986 Hemoregulatory compounds |
| 03/13/2001 | US6200955 Heparin binding peptides |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/13/2001 | US6200560 Adeno-associated virus vectors for expression of factor VIII by target cells |
| 03/13/2001 | CA2146238C Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 03/08/2001 | WO2001016603A2 Analysis and treatment of body weight and eating disorders |
| 03/08/2001 | WO2001016347A1 The hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from panax ginseng |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016321A1 Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016296A2 Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 03/08/2001 | WO2001016139A1 Androgen receptor modulator compounds and methods |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016133A2 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 03/08/2001 | WO2001016108A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/08/2001 | WO2001015668A1 Controlled release pellet formulation |
| 03/08/2001 | WO2001015665A1 Controlled release oral dosage suitable for oral administration |
| 03/08/2001 | WO2001015654A2 Low molecular weight antithrombotic polysaccharide |
| 03/08/2001 | WO2000076998B1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | WO2000039290A3 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | WO2000023588A8 G-protein coupled receptors |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | DE19940012A1 Eukaryotic expression plasmid useful for treating peripheral arterial occlusive disease, comprises two expression cassettes, one containing the gene for human vascular endothelial growth factor VEGF165 |
| 03/08/2001 | DE19937537A1 Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate 2-substituted derivatives Dialkylaminoalkylbiphenyl |
| 03/08/2001 | CA2384435A1 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2383381A1 Methods and compositions relating to body weight and eating disorders |
| 03/08/2001 | CA2383077A1 Androgen receptor modulator compounds and methods |
| 03/08/2001 | CA2378298A1 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1080676A1 Home-style decoctor endowed with steamy boiling function, and method of preparing red ginseng extract using the same |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/07/2001 | EP1080093A1 G-csf mimetics |
| 03/07/2001 | EP1080087A1 Novel 2-alkyl substituted imidazole compounds |
| 03/07/2001 | EP1080075A1 Piperididinyl and n-amidinopiperidinyl derivatives |
| 03/07/2001 | EP1079866A2 Methods of inhibiting clot formation |
| 03/07/2001 | EP1079835A1 Pyrazinone thrombin inhibitors |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079805A1 Pharmaceutical composition comprising factor viii and neutral liposomes |
| 03/07/2001 | EP1079791A2 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 03/07/2001 | EP0783505B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 03/07/2001 | CN1286684A Carboxamide derivs. of pyrrolidine, piperidine and hexahydroazepine for treatment of thrombosis disorders |
| 03/07/2001 | CN1286633A Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
| 03/07/2001 | CN1286262A Anticoagulant protein mediated by anticoagulant protein of human placenta |
| 03/07/2001 | CN1286116A Medicine for treating cerebral infarction and its preparing process |
| 03/07/2001 | CN1286108A Chinese medicine for treating apoplexy |
| 03/07/2001 | CN1286107A Chinese medicine for preventing apoplexy |
| 03/07/2001 | CN1286092A Medicine for eliminating thrombus and treating apoplexy |
| 03/07/2001 | CN1286090A Powdered medicine for treating internal hemorrhage |
| 03/07/2001 | CN1286066A Cooker with cooking function and method for preparing red ginseng extract using it |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062865C Process for production of amidinobenzofuran and amidinobenzothiophen derivs. and salt thereof |
| 03/06/2001 | US6197943 Preparation of a salt of an organic base of the starting glycosaminoglycans, partial solvolytic desulfation of the salts by treatment with aprotic polar solvent containing methanol, n-resulfation of the partially desulfated product |
| 03/06/2001 | US6197793 Hemoregulatory compounds |
| 03/06/2001 | US6197789 Antidiabetic agents |
| 03/06/2001 | US6197758 Methods for supplying postgastrectomic mineral and methods for treating postgastrectomic syndrome |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/06/2001 | US6197748 Ketoheterocyclic inhibitors of factor Xa |
| 03/06/2001 | US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| 03/06/2001 | US6197560 Efficient biosynthesis using aspergillus submerged culture by controlling carbon source feeding, nitrogen source feeding, glucose concentration, stirring rate, aeration rate, foam level, and culture volume to maintain steady state |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197194 Single use system for preparing autologous plasma and fibrin gel |
| 03/06/2001 | CA1341197C Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use |
| 03/01/2001 | WO2001014593A2 A method for producing quality assured biological sample and composition containing the same |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014396A1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor |
| 03/01/2001 | WO2001014358A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 03/01/2001 | WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 03/01/2001 | WO2001014338A1 NOVEL INTEGRIN αVβ3 INHIBITORS |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | WO2001013967A1 Solid wound healing formulations containing fibronectin |
| 03/01/2001 | WO2001013933A2 Agents for the enhanced oxygen delivery in mammals |
| 03/01/2001 | WO2001013924A1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 03/01/2001 | WO2001013917A1 Npy antagonists: spiroisoquinolinone derivatives |
| 03/01/2001 | WO2001013900A2 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 03/01/2001 | WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000071516B1 INHIBITORS OF FACTOR Xa |
| 03/01/2001 | WO2000066577A3 Brigded cycloalkanes as thromboxane ligands without blood clotting effects |
| 03/01/2001 | WO2000059535A3 suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF |
| 03/01/2001 | DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells |